Adagio Therapeutics Raises $80M Series B Round to Further Advance Best-In-Class Antibodies for Coronavirus Treatment and Prevention Read more
Forma Therapeutics Announces FT-4202 Receives Orphan Drug Designation In Europe For Treatment Of Sickle Cell Disease Read more
ImmunityBio, NantKwest Announce Positive Interim Phase 1 Safety Data of hAd5 COVID-19 Vaccine Dose Study Read more
ViiV Healthcare announces investigational injectable cabotegravir is superior to oral standard of care for HIV prevention in women Read more